Two-gene test predicts which patients with heart failure respond best to beta-blocker drug, study finds

Tampa, FL (Oct. 16, 2012) – A landmark paper identifying genetic signatures that predict which patients will respond to a life-saving drug for treating congestive heart failure has been published by a research team co-led by Stephen B. Liggett, MD, of the University of South Florida. Click Here to Read More

Leave a Reply

Your email address will not be published. Required fields are marked *